Reduced psychotropic drug use in Alzheimer patients receiving rivastigmine

被引：0
|
作者：
Verny, M
Fremont, P
Bourrin, JC
Pere, JJ
Bourdeix, I
Toulouse, M
机构：
[1] Hop La Pitie Salpetriere, Paris, France
[2] Ctr Hosp Gen, Lagny Sur Marne, France
[3] Novartis Pharma SAS, Rueil Malmaison, France
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80644-4
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [1] Psychotropic drug use in patients with Alzheimer's disease receiving rivastigmine
    Verny, M
    Fremont, P
    Bourrin, J
    Bourdeix, I
    Pere, J
    Toulouse, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S383 - S383
  • [2] Effect of Alzheimer's disease severity on psychotropic drug use and behavior in nursing home patients treated with rivastigmine
    Edwards, K
    Anand, R
    Koumaras, B
    Hartman, R
    [J]. GERONTOLOGIST, 2001, 41 : 24 - 24
  • [3] Effect if Alzheimer's disease severity on psychotropic drug use and behavior in nursing home patients treated with rivastigmine
    Edwards, K
    Anand, R
    Koumaras, B
    Hartman, R
    [J]. GERONTOLOGIST, 2001, 41 : 123 - 124
  • [4] Effect of Alzheimer's disease severity on psychotropic drug use and behavior in nursing home patients treated with rivastigmine
    Edwards, K
    Goodman, W
    Anand, R
    Koumaras, B
    Hartman, R
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S78 - S78
  • [5] Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine
    Dong-Churl Suh
    Stephen Arcona
    Simu K. Thomas
    Christopher Powers
    Adrian L. Rabinowicz
    Hyunchul Shin
    Dario Mirski
    [J]. Drugs & Aging, 2004, 21 : 395 - 403
  • [6] Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
    Suh, DC
    Arcona, S
    Thomas, SK
    Powers, C
    Rabinowicz, AL
    Shin, HC
    Mirski, D
    [J]. DRUGS & AGING, 2004, 21 (06) : 395 - 403
  • [7] Impact of rivastigmine on time to first antipsychotic drug use in patients with Alzheimer's disease
    Suh, DC
    Arcona, S
    Thomas, S
    Chang, S
    Powers, C
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 271 - 272
  • [8] Antiemetics mitigate nausea and vomiting in Alzheimer's patients receiving rivastigmine
    Cutler, NR
    Hartman, RD
    Messina, J
    Anand, R
    Sramek, JJ
    Jhee, SS
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 161S - 161S
  • [9] Psychotropic drug use and psychotropic polypharmacy among persons with Alzheimer's disease
    Orsel, Kim
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Tanskanen, Antti
    Tiihonen, Jari
    Gardarsdottir, Helga
    Hartikainen, Sirpa
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 294 - 294
  • [10] Decreased risk of first antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
    Suh, DC
    Arcona, S
    Thomas, SK
    Powers, C
    Rabinowicz, A
    Mirski, D
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 325 - 325
12345